{
  "docId": "019dd923-622c-750b-8b99-58801594b94c",
  "docSlug": "9551be67f14d",
  "documentTitle": "Perion Network Ltd. (PERI)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-05-23 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 36,
  "pageCount": 127,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses stock charts to visually demonstrate value destruction during the CEO's tenure.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "headshot",
    "screenshot",
    "line_chart",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-58801594b94c/36",
  "deckHref": "/decks/019dd923-622c-750b-8b99-58801594b94c",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-58801594b94c.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-58801594b94c#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.19,
        "x": 0.02,
        "y": 0.32
      },
      "kind": "callout",
      "text": "Biography At Panaya Claims \"World-Class Visionary Skills\" And \"Proven Track Record\"",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb38359b-cce4-4da8-ab2b-0e131561c4ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.48,
        "x": 0.02,
        "y": 0.51
      },
      "kind": "chart",
      "text": "Fibronics (Nasdaq/OTCBB: FBRX): Tenure, 1989 - 1996",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e1896c0-93f4-4687-801e-f802982b8f30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.48,
        "x": 0.51,
        "y": 0.51
      },
      "kind": "chart",
      "text": "Syneron Medical (Nasdaq: ELOS), Tenure May 2006 - Feb 2009",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c72db1d-eab2-453d-ae8c-5c81086d4dbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.08,
        "x": 0.22,
        "y": 0.32
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7a9e66f-72f7-4c61-8451-9f5ab91b5d0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.96,
        "x": 0.02,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "CEO Gerstel was also VP of Operations at Fibronics (Nasdaq / OTCBB FBRX) from 1989 – 1996. Its fortunes significantly declined and ultimately it merged with Elbit.(1) The financial controller at Fibronics was also the controller at ESC Medical Systems / Lumenis during the time of the accounting scandal.(2) Gerstel later was associated with Syneron Medical (Nasdaq: ELOS), joining as President of Syneron Inc. in May 2006 and became CEO in May 2007.(3) By the time he left in Feb 2009, the stock had fallen dramatically.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03d78ab4-cec5-4da3-bf25-dfe87548a59f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.66,
        "x": 0.32,
        "y": 0.32
      },
      "kind": "paragraph",
      "text": "Doron Gerstel has more than 20 years of entrepreneurial and executive experience in the high-tech industry. He has a proven track record of integrating strategic planning and operations with world-class visionary skills and creative management to achieve global business goals...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cec27fc4-ad0b-4c82-8bae-59bddd110a15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.96,
        "x": 0.02,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: Bloomberg and Panaya Biography of CEO Gerstel via Wayback Machine (1) Fibronics and Elbit merger (2) Raanan Yehiely, Controller of Fibronics and ESC Medical Systems (Lumenis), LinkedIn (3) “Syneron Medical Ltd. Announces Management Change...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d114cc2-d431-4a73-bbe3-e0fdd79db561",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "Gerstel's Other Public Company Ventures Didn't Work Out So Well",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30df57c7-7262-4858-b798-c1c07450f39c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "849996b6-4964-4c89-9013-a1044c3142bb",
      "evidence": "The slide frames the CEO as a villainous figure by highlighting past failures and scandals.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 127,
      "from": 6,
      "beatId": "31d83761-6e14-4d29-a0aa-1ff8a80344ff",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The deck spends most of its pages exposing contradictions and inconsistencies in PERI's financials, partnerships, and growth story.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 46,
      "from": 28,
      "beatId": "be2f5fa5-5c24-4708-a4c1-76cde4daf5c6",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Preempt Rebuttal",
      "beatSlug": null,
      "evidence": "The deck preempts potential rebuttals by addressing potential counterarguments and criticisms.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 127,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "e972ccdf-c217-46cb-9470-ba2f8b94de5a",
      "evidence": "The deck presents a series of logical and coherent arguments to build a case against PERI.",
      "position": 0,
      "objective": "To present a logical chain of evidence and reasoning to support the conclusion of significant downside risk to PERI's share price.",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.8,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}